Global Spatial Transcriptomics Sequencing Market Research Report 2025

Publication ID:

PB503252928

Publication Date:

March 12, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

IT Services [2]

Computing & Electronics [3]

Description:

The global market for Spatial Transcriptomics Sequencing was valued at US$ 138 million in the year 2024 and is projected to reach a revised size of US$ 249 million by 2031, growing at a CAGR of 8.7% during the forecast period.
Spatial transcriptomics sequencing is an advanced molecular biology technique that combines the principles of transcriptomics (the study of the complete set of RNA transcripts in a cell or tissue) with spatial information. It enables the simultaneous measurement of gene expression levels and the determination of the location of those transcripts within a tissue sample. By preserving the spatial context of gene expression, this technology provides a more comprehensive understanding of how genes are expressed in different regions of a tissue, which is crucial for elucidating complex biological processes, disease mechanisms, and cellular interactions. It typically involves methods to capture and sequence RNA molecules directly from specific locations within a tissue section, followed by computational analysis to map the gene expression data back to their spatial coordinates.
North American market for Spatial Transcriptomics Sequencing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Spatial Transcriptomics Sequencing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Spatial Transcriptomics Sequencing in Cancer Research is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Spatial Transcriptomics Sequencing include 10x Genomics, Illumina, Nanostring Technologies, Obio Scientific, Sinotech Genomics, Novogene, Shbio, Lianchuan Bio, novelbio, Majorbio, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Spatial Transcriptomics Sequencing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Spatial Transcriptomics Sequencing.
The Spatial Transcriptomics Sequencing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Spatial Transcriptomics Sequencing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Spatial Transcriptomics Sequencing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
10x Genomics
Illumina
Nanostring Technologies
Obio Scientific
Sinotech Genomics
Novogene
Shbio
Lianchuan Bio
novelbio
Majorbio
Biomarker
Segment by Type
Slide-based Spatial Transcriptomics
Microfluidic-based Spatial Transcriptomics
Others
Segment by Application
Cancer Research
Developmental Biology
Neuroscience
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Spatial Transcriptomics Sequencing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Spatial Transcriptomics Sequencing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Slide-based Spatial Transcriptomics
1.2.3 Microfluidic-based Spatial Transcriptomics
1.2.4 Others
1.3 Market by Application
1.3.1 Global Spatial Transcriptomics Sequencing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Cancer Research
1.3.3 Developmental Biology
1.3.4 Neuroscience
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Spatial Transcriptomics Sequencing Market Perspective (2020-2031)
2.2 Global Spatial Transcriptomics Sequencing Growth Trends by Region
2.2.1 Global Spatial Transcriptomics Sequencing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Spatial Transcriptomics Sequencing Historic Market Size by Region (2020-2025)
2.2.3 Spatial Transcriptomics Sequencing Forecasted Market Size by Region (2026-2031)
2.3 Spatial Transcriptomics Sequencing Market Dynamics
2.3.1 Spatial Transcriptomics Sequencing Industry Trends
2.3.2 Spatial Transcriptomics Sequencing Market Drivers
2.3.3 Spatial Transcriptomics Sequencing Market Challenges
2.3.4 Spatial Transcriptomics Sequencing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Spatial Transcriptomics Sequencing Players by Revenue
3.1.1 Global Top Spatial Transcriptomics Sequencing Players by Revenue (2020-2025)
3.1.2 Global Spatial Transcriptomics Sequencing Revenue Market Share by Players (2020-2025)
3.2 Global Top Spatial Transcriptomics Sequencing Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Spatial Transcriptomics Sequencing Revenue
3.4 Global Spatial Transcriptomics Sequencing Market Concentration Ratio
3.4.1 Global Spatial Transcriptomics Sequencing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Spatial Transcriptomics Sequencing Revenue in 2024
3.5 Global Key Players of Spatial Transcriptomics Sequencing Head office and Area Served
3.6 Global Key Players of Spatial Transcriptomics Sequencing, Product and Application
3.7 Global Key Players of Spatial Transcriptomics Sequencing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Spatial Transcriptomics Sequencing Breakdown Data by Type
4.1 Global Spatial Transcriptomics Sequencing Historic Market Size by Type (2020-2025)
4.2 Global Spatial Transcriptomics Sequencing Forecasted Market Size by Type (2026-2031)
5 Spatial Transcriptomics Sequencing Breakdown Data by Application
5.1 Global Spatial Transcriptomics Sequencing Historic Market Size by Application (2020-2025)
5.2 Global Spatial Transcriptomics Sequencing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Spatial Transcriptomics Sequencing Market Size (2020-2031)
6.2 North America Spatial Transcriptomics Sequencing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Spatial Transcriptomics Sequencing Market Size by Country (2020-2025)
6.4 North America Spatial Transcriptomics Sequencing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Spatial Transcriptomics Sequencing Market Size (2020-2031)
7.2 Europe Spatial Transcriptomics Sequencing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Spatial Transcriptomics Sequencing Market Size by Country (2020-2025)
7.4 Europe Spatial Transcriptomics Sequencing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Spatial Transcriptomics Sequencing Market Size (2020-2031)
8.2 Asia-Pacific Spatial Transcriptomics Sequencing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Spatial Transcriptomics Sequencing Market Size by Region (2020-2025)
8.4 Asia-Pacific Spatial Transcriptomics Sequencing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Spatial Transcriptomics Sequencing Market Size (2020-2031)
9.2 Latin America Spatial Transcriptomics Sequencing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Spatial Transcriptomics Sequencing Market Size by Country (2020-2025)
9.4 Latin America Spatial Transcriptomics Sequencing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Spatial Transcriptomics Sequencing Market Size (2020-2031)
10.2 Middle East & Africa Spatial Transcriptomics Sequencing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Spatial Transcriptomics Sequencing Market Size by Country (2020-2025)
10.4 Middle East & Africa Spatial Transcriptomics Sequencing Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 10x Genomics
11.1.1 10x Genomics Company Details
11.1.2 10x Genomics Business Overview
11.1.3 10x Genomics Spatial Transcriptomics Sequencing Introduction
11.1.4 10x Genomics Revenue in Spatial Transcriptomics Sequencing Business (2020-2025)
11.1.5 10x Genomics Recent Development
11.2 Illumina
11.2.1 Illumina Company Details
11.2.2 Illumina Business Overview
11.2.3 Illumina Spatial Transcriptomics Sequencing Introduction
11.2.4 Illumina Revenue in Spatial Transcriptomics Sequencing Business (2020-2025)
11.2.5 Illumina Recent Development
11.3 Nanostring Technologies
11.3.1 Nanostring Technologies Company Details
11.3.2 Nanostring Technologies Business Overview
11.3.3 Nanostring Technologies Spatial Transcriptomics Sequencing Introduction
11.3.4 Nanostring Technologies Revenue in Spatial Transcriptomics Sequencing Business (2020-2025)
11.3.5 Nanostring Technologies Recent Development
11.4 Obio Scientific
11.4.1 Obio Scientific Company Details
11.4.2 Obio Scientific Business Overview
11.4.3 Obio Scientific Spatial Transcriptomics Sequencing Introduction
11.4.4 Obio Scientific Revenue in Spatial Transcriptomics Sequencing Business (2020-2025)
11.4.5 Obio Scientific Recent Development
11.5 Sinotech Genomics
11.5.1 Sinotech Genomics Company Details
11.5.2 Sinotech Genomics Business Overview
11.5.3 Sinotech Genomics Spatial Transcriptomics Sequencing Introduction
11.5.4 Sinotech Genomics Revenue in Spatial Transcriptomics Sequencing Business (2020-2025)
11.5.5 Sinotech Genomics Recent Development
11.6 Novogene
11.6.1 Novogene Company Details
11.6.2 Novogene Business Overview
11.6.3 Novogene Spatial Transcriptomics Sequencing Introduction
11.6.4 Novogene Revenue in Spatial Transcriptomics Sequencing Business (2020-2025)
11.6.5 Novogene Recent Development
11.7 Shbio
11.7.1 Shbio Company Details
11.7.2 Shbio Business Overview
11.7.3 Shbio Spatial Transcriptomics Sequencing Introduction
11.7.4 Shbio Revenue in Spatial Transcriptomics Sequencing Business (2020-2025)
11.7.5 Shbio Recent Development
11.8 Lianchuan Bio
11.8.1 Lianchuan Bio Company Details
11.8.2 Lianchuan Bio Business Overview
11.8.3 Lianchuan Bio Spatial Transcriptomics Sequencing Introduction
11.8.4 Lianchuan Bio Revenue in Spatial Transcriptomics Sequencing Business (2020-2025)
11.8.5 Lianchuan Bio Recent Development
11.9 novelbio
11.9.1 novelbio Company Details
11.9.2 novelbio Business Overview
11.9.3 novelbio Spatial Transcriptomics Sequencing Introduction
11.9.4 novelbio Revenue in Spatial Transcriptomics Sequencing Business (2020-2025)
11.9.5 novelbio Recent Development
11.10 Majorbio
11.10.1 Majorbio Company Details
11.10.2 Majorbio Business Overview
11.10.3 Majorbio Spatial Transcriptomics Sequencing Introduction
11.10.4 Majorbio Revenue in Spatial Transcriptomics Sequencing Business (2020-2025)
11.10.5 Majorbio Recent Development
11.11 Biomarker
11.11.1 Biomarker Company Details
11.11.2 Biomarker Business Overview
11.11.3 Biomarker Spatial Transcriptomics Sequencing Introduction
11.11.4 Biomarker Revenue in Spatial Transcriptomics Sequencing Business (2020-2025)
11.11.5 Biomarker Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

Companies Mentioned:

10x Genomics
Illumina
Nanostring Technologies
Obio Scientific
Sinotech Genomics
Novogene
Shbio
Lianchuan Bio
novelbio
Majorbio
Biomarker

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂